GAMMA Investing’s Inhibrx, Inc. Common Stock INBX Stock Holding History

GAMMA Investing’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-31	Closed	-$1.08K	–	3556
2024 Q1	$1.08K	Buy	31 +21	+210%	+$766	﹤0.01%	2924
2023 Q4	$385	Buy	+10	New	+$214	﹤0.01%	3011

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

GAMMA Investing's INBX Position: Q2 2024 in Review

GAMMA Investing sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 31 shares — an estimated $1.08K sold.

GAMMA Investing first reported a position in INBX in Q4 2023 and held it in 2 quarters. The position peaked at $1.08K in Q1 2024. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

GAMMA Investing reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
GAMMA Investing sold 31 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $1.08K.
GAMMA Investing first reported a position in Inhibrx, Inc. Common Stock in Q4 2023 and held it in 2 quarters.
GAMMA Investing's Inhibrx, Inc. Common Stock position peaked at $1.08K in Q1 2024.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on GAMMA Investing's 13F filing for Q2 2024, filed 2 Jul 2024.